Formosa Pharmaceuticals, Inc. (TPE:6838)

Formosa Pharmaceuticals Revenue

In the year 2025, Formosa Pharmaceuticals had annual revenue of 9.50M TWD, down -93.38%. Formosa Pharmaceuticals had revenue of 3.23M in the quarter ending December 31, 2025, a decrease of -45.28%.

• Revenue: 9.50M
• Revenue Growth: -93.38%
• P/S Ratio: 427.73
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.50M	-133.86M	-93.38%
Dec 31, 2024	143.36M	112.18M	359.89%
Dec 31, 2023	31.17M	29.86M	2,270.49%
Dec 31, 2022	1.32M	-27.21M	-95.39%
Dec 31, 2021	28.53M	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error